查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1843653

2025年全球癌症诊断人工智慧市场报告

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，人工智慧在癌症诊断领域的市场规模呈指数级增长，预计从2024年的3.9亿美元增长到2025年的5.2亿美元，复合年增长率达32.6%。预测期内的成长可归因于癌症发生率的上升、巨量资料的可用性、个人化肿瘤学的兴起、精准医疗的努力以及基因组数据的整合。

预计未来几年，人工智慧在癌症诊断领域的市场规模将呈指数级增长，到2029年将达到15.4亿美元，复合年增长率（CAGR）为31.1%。预测期内的成长主要受以下因素驱动：临床医生短缺、人口老化、远距远端医疗的全球普及、人工智慧与电子健康记录的整合以及癌症筛检计画的增加。预测期内的关键趋势包括：人工智慧演算法的快速发展、成像技术的进步、病理学的创新、放射组学和放射基因组学的进步、药物研发、深度学习以及用于预测性生物标记发现的人工智慧。

人工智慧（AI）在癌症诊断中的应用，是指运用先进的计算技术和演算法来辅助癌症的检测、诊断和表征。这项技术旨在提高癌症影像检查的速度、准确性和效率，并力求在检测乳房X光摄影异常方面达到与放射科医师相当的准确度。

人工智慧在癌症诊断中的主要组成部分包括软体解决方案、硬体和服务。软体解决方案是指为满足特定业务需求而客製化的应用程式或系统。癌症诊断中的人工智慧软体利用机器学习演算法和电脑视觉技术分析医学影像、基因数据和临床记录，从而实现精准的癌症检测、分类和治疗预测。这些人工智慧应用已应用于多种癌症，包括乳癌、肺癌、摄护腺癌、大肠癌和脑肿瘤。其应用涵盖筛检、诊断、肿瘤识别、监测和治疗计划制定，并被医院、医学研究机构、诊断中心和受託研究机构广泛使用。

美国2025年关税上调及其引发的贸易紧张局势正对资讯科技产业产生重大影响，尤其是在硬体製造、资料基础设施和软体部署方面。进口半导体、电路基板和网路设备的关税提高，并推高了高科技公司、云端服务供应商和资料中心的生产和营运成本。在全球范围内采购笔记型电脑、伺服器和消费电子产品零件的公司面临更长的前置作业时间和价格压力。同时，对专用软体征收的关税以及主要国际市场的报復性措施扰乱了全球IT供应链，并降低了海外对美国製造技术的需求。为了应对这些挑战，该行业正在加大对国内晶片生产的投资，扩大供应商网络，并利用人工智慧驱动的自动化技术来增强韧性并更有效地控製成本。

《人工智慧在癌症诊断中的应用市场研究报告》是商业研究公司最新发布的系列报告之一，提供人工智慧在癌症诊断领域的市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和商业机会。本市场研究报告对该行业的现状和未来发展趋势进行了深入分析，为您提供全面全面的市场概览。

未来五年31.1%的成长率预测较先前的预测略微下调了0.1%。这一下调主要归因于美国与其他国家之间的关税影响。关税可能透过增加人工智慧驱动的切片检查分析系统和病理工具的成本，尤其是德国和日本製造的产品，来抑制医疗保健创新。此外，相互关税以及不断升级的贸易紧张局势和限制措施对全球经济和贸易造成的负面影响也将使这种影响更加广泛。

癌症发生率的不断上升预计将推动人工智慧在癌症诊断市场的发展。癌症的特征是细胞不受控制地增殖，影响多个器官，是全球发病率和死亡率的重要原因。人工智慧在癌症诊断中发挥关键作用，它能够对医学影像数据进行准确且有效率的分析，有助于早期发现和准确分类癌变病灶。例如，总部位于瑞士的政府间组织—世界卫生组织（WHO）在2024年2月报告称，2022年全球新增癌症病例约2,000万例，死亡人数约970万。据估计，癌症确诊五年后，约有5,350万人仍存活。因此，癌症发生率的不断上升预计将推动人工智慧在癌症诊断市场的发展。

医疗基础设施的持续加强预计将在短期内推动人工智慧在癌症诊断市场的发展。医疗基础设施涵盖了支撑医疗服务的基本框架、设施、资源和流程，对于人工智慧技术的无缝整合至关重要。强大的医疗基础设施能够将人工智慧融入临床工作流程，确保资料安全和隐私，并促进医疗机构之间的协作。值得注意的是，澳洲卫生与老年护理部于2022年3月宣布，将在2022-2023财年和2025-2026财年分别拨款1,320亿美元和1,400亿美元用于医疗基础建设。未来四年总计5,370亿美元的投入，凸显了医疗基础设施的改善在推动人工智慧在癌症诊断市场发展中的关键作用。

技术进步已成为人工智慧在癌症诊断市场中日益显着的发展趋势。领先的市场参与者正致力于开发针对各种癌症的创新工具，从而巩固其市场地位。例如，总部位于新加坡的Qritive公司于2023年3月推出了QAi Prostate，这是一款用于前列腺癌诊断的先进人工智慧工具。 QAi Prostate专注于为病理学家提供人工智慧解决方案。它能够准确识别前列腺癌区域，并对切片检查组织样本中的恶性肿瘤和良性肿瘤区域进行分类。该工具提供每张切片或感兴趣区域中肿瘤大小和百分比的详细摘要，帮助病理学家快速做出明智的决策。

在癌症诊断人工智慧市场中，领先企业正积极寻求策略联盟，将其视为加速人工智慧技术部署的关键途径。此类伙伴关係能够充分利用合作企业的优势和资源，并实现互利共赢。例如，2023年10月，罗氏公司(F. Hoffmann-La Roche AG)与Ibex Medical Analytics和亚马逊网路服务(AWS)达成合作。透过此次合作，病理实验室将能够使用navify数位病理软体平台，并利用Ibex的人工智慧决策支援功能，辅助医师诊断乳癌和摄护腺癌。 Ibex Medical Analytics、罗氏和AWS之间的伙伴关係将打造创新的人工智慧流程，加速数位病理学的发展，并为病理实验室提供可扩展的解决方案。

2022年1月，总部位于美国的放射学资讯技术解决方案公司RadNet收购了Aidence Holding BV和Quantib BV。此次策略性收购旨在利用人工智慧技术，拓展肺癌和摄护腺癌诊断与筛检领域的机会。总部位于荷兰的Aidence Holding BV专注于肺癌诊疗流程中的人工智慧临床应用，而Quantib BV则专注于前列腺癌的人工智慧和机器学习解决方案。

癌症诊断人工智慧市场的主要参与者包括微软公司、辉瑞公司、强生公司、西门子、罗氏控股公司、Google有限责任公司、国际商业机器公司、赛默飞世尔科技公司、甲骨文公司、通用电气医疗集团、Illumina公司、Bio-Rad Laboratorophcoco、Healthtiron Health公司、Tempus Labs、Paige AIco、Acco 这些公司、Dock、Healthtiron HealthSel、Apia Labs Diagnostics公司、Prognos Health公司、Aidence公司、Kheiron Medical Technologies Limited公司、Zebra Medical Vision公司、Niramai公司、Enlitic公司、Therapixel公司、Medial EarlySign Ltd.公司、Freenome公司和SkinVision BV公司。

2024年，北美是人工智慧癌症诊断市场最大的区域。预计亚太地区将在预测期内成为成长最快的区域。这份人工智慧癌症诊断市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。

癌症诊断人工智慧市场报告涵盖的国家包括澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大。

癌症诊断人工智慧（AI）市场由提供数据分析、影像识别、个人化医疗和决策支援等服务的营业单位所获得的收入所构成。市场价值还包括服务供应商销售的任何相关商品或包含在其服务产品中的任何商品的价值。癌症诊断人工智慧（AI）市场还包括基于人工智慧的诊断工具、预测分析工具和虚拟肿瘤委员会的销售。该市场的价值为“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧在癌症诊断的应用：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球癌症诊断人工智慧市场：成长率分析
  • 全球癌症诊断人工智慧市场表现：规模与成长，2019-2024年
  • 全球癌症诊断人工智慧市场预测：规模与成长，2024-2029年，2034年
  • 全球癌症诊断人工智慧：潜在市场规模 (TAM)

第六章 市场细分

  • 全球癌症诊断人工智慧市场：按组件、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 软体解决方案
  • 硬体
  • 服务
  • 全球癌症诊断人工智慧市场（按癌症类型、效能和预测划分，2019-2024年、2024-2029年、2034年）
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 大肠直肠癌
  • 脑肿瘤
  • 其他的
  • 全球癌症诊断人工智慧市场：按应用、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 筛检和诊断
  • 肿瘤识别
  • 监测
  • 治疗
  • 全球癌症诊断人工智慧市场（按最终用户、效能和预测划分，2019-2024年、2024-2029年、2034年）
  • 医院
  • 医学研究所
  • 诊断中心
  • 受託研究机构
  • 全球癌症诊断人工智慧市场：软体解决方案细分、类型、效能和预测（2019-2024年、2024-2029年、2034年）
  • 影像分析软体
  • 预测分析软体
  • 决策支援系统
  • 资料管理平台
  • 全球癌症诊断人工智慧市场：硬体细分、类型、效能和预测（2019-2024年、2024-2029年、2034年）
  • 影像设备
  • 生物标记检测装置
  • 计算基础设施
  • 全球癌症诊断人工智慧市场：服务细分、类型、效能和预测（2019-2024年、2024-2029年、2034年）
  • 咨询服务
  • 实施服务
  • 维护和支援服务
  • 培训服务

第七章 区域和国家分析

  • 全球癌症诊断人工智慧市场：按地区、绩效和预测划分，2019-2024年、2024-2029年、2034年
  • 全球癌症诊断人工智慧市场按国家划分、表现及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 人工智慧在癌症诊断市场的应用：竞争格局
  • 人工智慧在癌症诊断市场的应用：公司概况
    • 微软公司概况、产品和服务、策略和财务分析
    • 辉瑞公司概况、产品和服务、策略和财务分析
    • 强生公司概况、产品与服务、策略与财务分析
    • 西门子概览、产品与服务、策略与财务分析
    • 罗氏控股公司概况、产品与服务、策略与财务分析

第31章：其他领先和创新企业

  • Google LCC
  • International Business Machines Corporation
  • Thermo Fisher Scientific Inc.
  • Oracle Corporation
  • GE Healthcare
  • Illumina Inc.
  • Bio Rad Laboratories Inc.
  • Flatiron Health
  • Tempus Labs Inc.
  • Paige AI Inc.
  • OncoHealth Corporation
  • Path AI Inc.
  • Aidoc
  • Sophia Genetics SA
  • Digital Diagnostics Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年人工智慧在癌症诊断市场的应用：提供新机会的国家
  • 2029年人工智慧在癌症诊断市场的应用：新兴领域蕴藏新的机会
  • 2029年人工智慧在癌症诊断市场的应用：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r24683u

Artificial intelligence (AI) in cancer diagnostics involves the application of advanced computational techniques and algorithms to aid in the detection, diagnosis, and characterization of cancer. This technology is employed to enhance the speed, accuracy, and efficiency of cancer imaging tests, achieving comparable accuracy to radiologists in detecting mammographic abnormalities.

The main components of artificial intelligence in cancer diagnostics include software solutions, hardware, and services. Software solutions are customized applications or systems designed to address specific business needs, and AI-powered software in cancer diagnostics utilizes machine learning algorithms and computer vision techniques to analyze medical images, genetic data, and clinical records. This enables accurate cancer detection, classification, and treatment prediction. These AI applications are utilized in various types of cancer such as breast cancer, lung cancer, prostate cancer, colorectal cancer, and brain tumors. They are applied in screening and diagnosis, tumor identification, surveillance, and treatment planning and are used by hospitals, medical research institutes, diagnostic centers, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The artificial intelligence in cancer diagnostics research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in cancer diagnostics market statistics, including the artificial intelligence in cancer diagnostics industry's global market size, regional shares, competitors with an artificial intelligence in cancer diagnostics market share, detailed artificial intelligence in cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cancer diagnostics industry. This artificial intelligence in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.39 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 32.6%. The growth in the historic period can be attributed to increased cancer incidence, big data availability, rise of personalized oncology, precision medicine initiatives, integration of genomic data.

The artificial intelligence in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.54 billion in 2029 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to clinician shortages, population aging, global telemedicine adoption, integration of ai with electronic health records, growing cancer screening programs. Major trends in the forecast period include rapid advances in ai algorithms, advancements in imaging technology, technological innovations in pathology, advancements in radiomics and radiogenomics, drug development, deep learning, ai for predictive biomarker discovery.

The forecast of 31.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Healthcare innovation might be hindered as tariffs increase costs for AI-powered biopsy analysis systems and pathology tools, especially those manufactured in Germany and Japan The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is anticipated to drive the growth of artificial intelligence in the cancer diagnostics market in the future. Cancer is characterized by uncontrolled cell growth affecting various organs, contributing significantly to morbidity and mortality worldwide. Artificial intelligence plays a crucial role in cancer diagnostics by enabling accurate and efficient analysis of medical imaging data, which aids in the early detection and precise classification of cancerous lesions. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that in 2022, there were approximately 20 million new cancer cases, resulting in 9.7 million deaths. An estimated 53.5 million individuals were alive five years after their cancer diagnosis. Therefore, the rising prevalence of cancer is expected to boost the growth of artificial intelligence in the cancer diagnostics market.

The ongoing enhancement of healthcare infrastructure is poised to drive the artificial intelligence in cancer diagnostics market in the foreseeable future. Healthcare infrastructure, encompassing the fundamental framework, facilities, resources, and processes supporting healthcare services, is crucial for the seamless integration of AI technologies. A robust healthcare infrastructure enables the incorporation of AI into clinical workflows, ensures data security and privacy, and facilitates collaborative efforts across healthcare institutions. Notably, in March 2022, the Department of Health and Aged Care in Australia announced a substantial allocation of $132 billion to healthcare infrastructure in 2022-23, rising to $140 billion in 2025-26. This commitment of $537 billion over the next four years underscores the pivotal role of improving healthcare infrastructure in propelling the artificial intelligence in cancer diagnostics market.

Technological advancement emerges as a prominent trend gaining momentum in the artificial intelligence in the cancer diagnostics market. Key market players are focused on developing innovative tools catering to various cancer conditions, thereby fortifying their market positions. For instance, in March 2023, Qritive, a Singapore-based company specializing in AI-powered solutions for pathologists, introduced QAi Prostate-an advanced AI-powered tool for prostate cancer diagnosis. QAi Prostate accurately identifies prostatic adenocarcinoma regions and classifies malignant and benign tumor areas in biopsy tissue samples. This tool provides detailed summaries of tumor size and percentage for each slide or region of interest, empowering pathologists to make informed decisions rapidly.

Strategic collaborations are a significant approach adopted by major companies operating in the artificial intelligence in cancer diagnostics market to expedite the deployment of AI-powered technologies. Such partnerships leverage the strengths and resources of collaborating entities for mutual benefits. For instance, in October 2023, F. Hoffmann-La Roche AG collaborated with Ibex Medical Analytics and Amazon Web Services. This collaboration allows pathology labs to utilize the navify Digital Pathology software platform to access Ibex's AI-powered decision support capabilities, aiding physicians in diagnosing breast and prostate cancer. The partnership between Ibex Medical Analytics, Roche, and Amazon Web Services generates innovative AI-powered processes, fostering advancements in digital pathology and offering scalable solutions for pathology laboratories.

In January 2022, RadNet, a US-based radiology information technology solutions company, acquired Aidence Holding B.V. and Quantib B.V. This strategic acquisition addresses opportunities in lung and prostate cancer diagnosis and screening through artificial intelligence. Aidence Holding B.V., based in the Netherlands, focuses on AI-powered clinical applications for the lung cancer pathway, while Quantib B.V. specializes in AI and machine learning solutions for prostate cancer.

Major companies operating in the artificial intelligence in cancer diagnostics market include Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V.

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in the cancer diagnostics market consists of revenues earned by entities by providing services such as data analysis, image recognition, personalized medicine, and decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the cancer diagnostics market also includes sales of AI-based diagnostic tools, predictive analytics tools, and a virtual tumor board. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software Solutions; Hardware; Services
  • 2) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Types
  • 3) By Application: Screening And Diagnosis; Tumor Identification; Surveillance; Treatment
  • 4) By End-User: Hospitals; Medical Research Institute; Diagnostic Centers; Contract Research Organization
  • Subsegments:
  • 1) By Software Solutions: Imaging Analysis Software; Predictive Analytics Software; Decision Support Systems; Data Management Platforms
  • 2) By Hardware: Imaging Devices; Biomarkers Detection Equipment; Computing Infrastructure
  • 3) By Services: Consulting Services; Implementation Services; Maintenance And Support Services; Training Services
  • Companies Mentioned: Microsoft Corporation; Pfizer Inc.; Johnson & Johnson's; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Oracle Corporation; GE Healthcare; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Cancer Diagnostics Market Characteristics

3. Artificial Intelligence In Cancer Diagnostics Market Trends And Strategies

4. Artificial Intelligence In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence In Cancer Diagnostics Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence In Cancer Diagnostics Total Addressable Market (TAM)

6. Artificial Intelligence In Cancer Diagnostics Market Segmentation

  • 6.1. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Solutions
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Other Types
  • 6.3. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening And Diagnosis
  • Tumor Identification
  • Surveillance
  • Treatment
  • 6.4. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Medical Research Institute
  • Diagnostic Centers
  • Contract Research Organization
  • 6.5. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Analysis Software
  • Predictive Analytics Software
  • Decision Support Systems
  • Data Management Platforms
  • 6.6. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Devices
  • Biomarkers Detection Equipment
  • Computing Infrastructure
  • 6.7. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation Services
  • Maintenance And Support Services
  • Training Services

7. Artificial Intelligence In Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market

  • 8.1. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Cancer Diagnostics Market

  • 9.1. China Artificial Intelligence In Cancer Diagnostics Market Overview
  • 9.2. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Cancer Diagnostics Market

  • 10.1. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Cancer Diagnostics Market

  • 11.1. Japan Artificial Intelligence In Cancer Diagnostics Market Overview
  • 11.2. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Cancer Diagnostics Market

  • 12.1. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Cancer Diagnostics Market

  • 13.1. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Cancer Diagnostics Market

  • 14.1. South Korea Artificial Intelligence In Cancer Diagnostics Market Overview
  • 14.2. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Cancer Diagnostics Market

  • 15.1. Western Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • 15.2. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Cancer Diagnostics Market

  • 16.1. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Cancer Diagnostics Market

  • 17.1. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Cancer Diagnostics Market

  • 18.1. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Cancer Diagnostics Market

  • 19.1. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Cancer Diagnostics Market

  • 20.1. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market

  • 21.1. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Cancer Diagnostics Market

  • 22.1. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Cancer Diagnostics Market

  • 23.1. North America Artificial Intelligence In Cancer Diagnostics Market Overview
  • 23.2. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Cancer Diagnostics Market

  • 24.1. USA Artificial Intelligence In Cancer Diagnostics Market Overview
  • 24.2. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Cancer Diagnostics Market

  • 25.1. Canada Artificial Intelligence In Cancer Diagnostics Market Overview
  • 25.2. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Cancer Diagnostics Market

  • 26.1. South America Artificial Intelligence In Cancer Diagnostics Market Overview
  • 26.2. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Cancer Diagnostics Market

  • 27.1. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Cancer Diagnostics Market

  • 28.1. Middle East Artificial Intelligence In Cancer Diagnostics Market Overview
  • 28.2. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Cancer Diagnostics Market

  • 29.1. Africa Artificial Intelligence In Cancer Diagnostics Market Overview
  • 29.2. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape
  • 30.2. Artificial Intelligence In Cancer Diagnostics Market Company Profiles
    • 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Johnson & Johnson's Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Cancer Diagnostics Market Other Major And Innovative Companies

  • 31.1. Google LCC
  • 31.2. International Business Machines Corporation
  • 31.3. Thermo Fisher Scientific Inc.
  • 31.4. Oracle Corporation
  • 31.5. GE Healthcare
  • 31.6. Illumina Inc.
  • 31.7. Bio Rad Laboratories Inc.
  • 31.8. Flatiron Health
  • 31.9. Tempus Labs Inc.
  • 31.10. Paige AI Inc.
  • 31.11. OncoHealth Corporation
  • 31.12. Path AI Inc.
  • 31.13. Aidoc
  • 31.14. Sophia Genetics SA
  • 31.15. Digital Diagnostics Inc.

32. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Cancer Diagnostics Market

34. Recent Developments In The Artificial Intelligence In Cancer Diagnostics Market

35. Artificial Intelligence In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer